510(k) device
Cyperus
Contrario Medical, Inc. · Labware, Assisted Reproduction (MQK, Class II) · First FDA decision Oct 26, 2026, newest Oct 26, 2026Infertility
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Cyperus"
MAUDE reports
0
Brand "Cyperus", since 2015
PubMed studies
1,270
Mentioning "Cyperus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cyperus
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Cyperus510(k)
K262276 · Decided Oct 26, 2026 · 112 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cyperus", any status and sponsor, newest update first.
No registered device study names "Cyperus".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cyperus", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MQK
2 reports: 2 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Cyperus"[tiab]. The summary above synthesizes these.
- Topical Cyperus rotundus oil: a new therapeutic modality with comparable efficacy to Alexandrite laser photo-epilation.
Mohammed GF · Aesthet Surg J · 2014Randomized Controlled Trial
- Cyperus peptide SFRWQ inhibits oxidation and inflammation in RAW264.7 cell model.
Ma C, Wu X · Int J Biol Macromol · 2024
- A seed-like proteome in oil-rich tubers.
Niemeyer PW, Irisarri I, Scholz P, et al. · Plant J · 2022Research Support, Non-U.S. Gov't
- Cyperus spp.: A Review on Phytochemical Composition, Biological Activity, and Health-Promoting Effects.
Taheri Y, Herrera-Bravo J, Huala L, et al. · Oxid Med Cell Longev · 2021Review
- Cyperus iria aqueous-ethanol extract ameliorated hyperglycemia, oxidative stress, and regulated inflammatory cytokines in streptozotocin-induced diabetic rats.
Saeed M, Sharif A, Hassan SU, et al. · Environ Sci Pollut Res Int · 2022
- Cyperus rotundus L. reverses the olanzapine-induced weight gain and metabolic changes-outcomes from network and experimental pharmacology.
Kanagali SN, Patil BM, Khanal P, et al. · Comput Biol Med · 2022
- Tiger Nut (Cyperus esculentus L.): Nutrition, Processing, Function and Applications.
Yu Y, Lu X, Zhang T, et al. · Foods · 2022Review
- Antidiarrhoeal activity of Cyperus rotundus.
Uddin SJ, Mondal K, Shilpi JA, et al. · Fitoterapia · 2006
- Effects of a Cyperus esculentus L. plant-based beverage on FVB/n female mice.
Fernandes FA, Oliveira PA, Pinto ML, et al. · Food Chem Toxicol · 2024
- Biochar from Cyperus alternifolius Linn.: from a waste of phytoremediation processing to efficient depolluting agent.
Nguyen LTT, Le PT, Nguyen TA, et al. · Environ Sci Pollut Res Int · 2023
- Planting Cyperus esculentus augments soil microbial biomass and diversity, but not enzymatic activities.
Duan Y, Ren W, Zhao J, et al. · PeerJ · 2022Research Support, Non-U.S. Gov't
- Cyperus rotundus Extract and Its Active Metabolite α-Cyperone Alleviates Paclitaxel-Induced Neuropathic Pain via the Modulation of the Norepinephrine Pathway.
Park KT, Sim I, Lee JC, et al. · Metabolites · 2024
Other devices of this type
Also filed under product code MQK.
- VitriGuardOrigio A/S · 510(k) 2020
- Rapid-i KitVitrolife Sweden AB · 510(k) 2019
- Pleiades DeviceMy123Baby Medical Limited Dba Boost Fertility · 510(k) 2026
- Fertilis microICSI DeviceFertilis Pty, Ltd. · 510(k) 2026
- SperSort Sperm Sorting Chip (IPG02)Ipreg Incorporation · 510(k) 2025
- Minvitro® Vitrification Straw (MVT-VSN series, including MVT-VSNRGuangzhou Hehong Biotech Co., Ltd. · 510(k) 2025
- SwimCount® Harvester (1 mL)Motilitycount Aps · 510(k) 2025
- cryo-GO Vitrification DeviceFujifilm Irvine Scientific · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.